resveratrol has been researched along with Obesity in 230 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (9.13) | 29.6817 |
| 2010's | 163 (70.87) | 24.3611 |
| 2020's | 46 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattarai, BR; Cho, H; Kafle, B; Lee, KH; Shrestha, S | 1 |
| Afonso, C; Almeida, T; Azevedo, C; Correia-da-Silva, M; Freitas, S; Moreira, J; Palmeira, A; Pinto, M; Sousa, E; Urbatzka, R; Vasconcelos, V | 1 |
| Apryatin, SA; Gmoshinski, IV; Nikityuk, DB; Riger, NA; Shipelin, VA; Shumakova, AA; Timonin, AN; Trusov, NV | 1 |
| Rabbani, N; Thornalley, PJ | 1 |
| Chin, V; Hillsley, A; Li, A; McLachlan, CS | 1 |
| Azzollini, D; Bordea, IR; Brienza, N; Ceci, S; Coloccia, G; Corriero, A; D'Oria, MT; De Leonardis, N; Del Fabbro, M; Di Pede, C; Dipalma, G; Ferati, AB; Ferati, K; Garibaldi, MG; Garofoli, G; Hazballa, D; Inchingolo, AD; Inchingolo, AM; Inchingolo, F; Jones, M; Kruti, Z; Lorusso, F; Macchia, L; Malcangi, G; Mancini, A; Maspero, C; Montenegro, V; Nucci, L; Palmieri, G; Patano, A; Piras, F; Rapone, B; Scarano, A; Semjonova, A; Settanni, V; Tartaglia, GM; Tarullo, A | 1 |
| Chen, F; Hu, X; Ma, Y; Wang, D; Wang, P; Zhao, W; Zhao, X | 1 |
| Chen, L; Gao, T; Han, Y; He, X; Li, D; Meng, X; Sun, Y; Wang, X; Zhang, J; Zhao, P | 1 |
| Barber, TM; Kabisch, S; Pfeiffer, AFH; Randeva, HS; Weickert, MO | 1 |
| Abo Alrob, O; Al-Horani, RA; Altaany, Z; Nusair, MB | 1 |
| Ehtesham, E; Habib, SH; Hassan, S; Malik, MO; Rauf, B; Shah, M | 1 |
| Le, TT; Urasaki, Y | 1 |
| Duttaroy, AK; Jena, AB; Kerry, RG; Patnaik, D | 1 |
| Beaumont, P; Courtois, A; Eseberri, I; Gómez-Zorita, S; Krisa, S; Milton-Laskibar, I; Portillo, MP | 1 |
| Elamir, AM; Elsayed, AM; Golam, RM; Ibrahim, NA; Merzeban, DH; Shamardl, HAMA | 1 |
| Cui, Y; Gao, X; Huang, Y; Jiang, Q; Luo, Y; Sun, W; Wang, Q; Wei, C; Yang, B; Zhang, S | 1 |
| Baek, SH; Kim, JS; Monmai, C | 1 |
| Chung, JY; Kim, OY; Song, J | 1 |
| Frendo-Cumbo, S; MacPherson, REK; Yang, AJT | 1 |
| Chen, WK; Ho, CT; Koh, YC; Lee, TL; Nagabhushanam, K; Pan, MH; Wang, B | 1 |
| Gu, H; He, J; Huang, Y; Jiang, M; Liu, L; Xu, X; Yang, Y | 1 |
| Culum, AA; Yurekli, M | 1 |
| Chen, C; Ling, MY; Lv, ZM | 1 |
| Babaei Khorzoughi, R; Hosseini, H; Meshkani, R; Pasalar, P; Sadeghi, A; Shabani, M; Teimouri, M | 1 |
| Chen, F; Chen, X; Gao, J; Hu, X; Jia, Y; Ke, W; Li, D; Liu, R; Wang, J; Wang, P; Wang, X | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Chen, CC; Huang, LT; Lai, YJ; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Tsai, CK; Tsai, TA; Yu, HR | 1 |
| Chen, F; Hu, X; Ke, W; Li, D; Wang, J; Wang, P | 1 |
| Hsu, MH; Huang, LT; Lin, IC; Sheen, JM; Tain, YL; Tiao, MM; Yu, HR | 1 |
| Andrade, JMO; Barcala-Jorge, AS; Batista-Jorge, GC; de Paula, AMB; Guimarães, ALS; Lelis, DF; Santos, SHS; Silveira, MF | 1 |
| Chen, CC; Hsu, TY; Huang, LT; Lai, YJ; Lin, IC; Lin, YJ; Liu, TY; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Yu, HR | 1 |
| Asbaghi, O; Eslampour, E; Ghaedi, E; Hadi, A; Miraghajani, M; Moodi, V; Shirinbakhshmasoleh, M | 1 |
| Gmoshinski, IV; Mzhelskaya, KV; Riger, NА; Shipelin, VА; Shumakova, АА; Timonin, АN; Trusov, NV; Аpryatin, SА | 1 |
| Corpas, R; Gatius, A; Griñán-Ferré, C; Pallàs, M; Rodríguez-Farré, E; Sanfeliu, C; Sarroca, S; Vilchez, D | 1 |
| Caputo, EL; Delpino, FM; Figueiredo, LM; Gigante, DP; Mintem, GC | 1 |
| Acton, JP; Bailey, SJ; Clifford, T; Cocksedge, SP; Davies, KAB | 1 |
| Griñán-Ferré, C; Izquierdo, V; Pallàs, M; Palomera-Ávalos, V | 1 |
| El-Demerdash, E; Elsherbiny, DA; Gerges, SH; Wahdan, SA | 1 |
| Gmoshinski, IV; Leontyeva, EV; Shipelin, VA; Shumakova, AA | 1 |
| Hichami, A; Khan, NA; Murtaza, B; Nani, A; Sayed Khan, A | 1 |
| Becer, E; Hoca, M; Vatansever, HS | 1 |
| Abbasi, M; Brandi, L; Daquinag, AC; Dawson, JA; Fan, Z; Hao, L; Keyel, PA; Kolonin, MG; Mechref, Y; Moustaid-Moussa, N; Nie, S; San Francisco, SK; Sun, X; Wang, S; Warraich, I; Wu, D; Zabet-Moghaddam, M; Zhang, R; Zhao, L; Zu, Y | 1 |
| Bava, I; Bosco, F; Cardamone, A; Carresi, C; Coppoletta, AR; Gliozzi, M; Guarnieri, L; Macrì, R; Maiuolo, J; Mollace, R; Mollace, V; Musolino, V; Nucera, S; Palma, E; Ragusa, M; Ruga, S; Scarano, F; Scicchitano, M; Zito, MC | 1 |
| Calogero, AE; Cannarella, R; Cimino, L; Compagnone, M; Condorelli, RA; La Vignera, S; Mongioì, LM | 1 |
| Argente, J; Chowen, JA; Ros, P | 1 |
| Du, M; Mao, X; Niu, W; Wang, B; Wang, H | 1 |
| Chang, SKC; Chen, YW; Hou, CY; Hsu, WH; Liao, JX; Shih, MK; Tain, YL; Yeh, YT | 1 |
| Bressan, J; da Conceição, AR; de Souza Vilela, DL; Fraiz, GM; Hermsdorff, HHM; Rocha, DMUP | 1 |
| Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
| Blaak, EE; de Ligt, M; Goossens, GH; Hesselink, MKC; Hoebers, N; Jorgensen, J | 1 |
| Dong, C; Hu, C; Jin, P; Li, N; Li, Q; Ma, Y; Peng, J; Qin, C; Wang, K; Wu, Y; Xiong, X; Yang, Z | 1 |
| Belles, C; Briot, A; Carpéné, C; Fernández-Quintela, A; Gomez-Zorita, S; Portillo, MP | 1 |
| Baer, DJ; Chen, TY; Ferruzzi, MG; Gebauer, SK; Ho, L; Novotny, JA; Pasinetti, GM; Terekhov, AI | 1 |
| Fernández-Quintela, A; González, M; Milton-Laskibar, I; Portillo, MP | 1 |
| Chen, J; Gao, K; Jia, C; Murtaza, G; Tian, G; Wahab, A; Zhang, F | 1 |
| Beaudoin, MS; Connor, MK; Sauvé, OS; Theriau, CF; Wright, DC | 1 |
| Bidault, G; Brighenti, F; Crozier, A; Del Rio, D; Mele, L; Mena, P; Vidal-Puig, A | 1 |
| Chen, B; Shen, J; Wan, L; Xiao, Z; Yi, T; Zhao, Y; Zhu, Y | 1 |
| Bird, JK; Raederstorff, D; Steinert, RE; Weber, P | 1 |
| Beaudoin, MS; Foute-Nelong, J; Gaudio, N; Mutch, DM; Reed, JK; Wright, DC | 1 |
| Ma, W; Shen, H; Tian, F; Zhang, Q; Zhao, L; Zhou, M | 1 |
| Aguirre, L; Fernández-Quintela, A; Gómez-Zorita, S; González, M; Milton-Laskibar, I; Portillo, MP | 1 |
| Bowers, LW; Cui, Z; DiGiovanni, J; Doerstling, SS; Ford, NA; Glickman, RD; Hursting, SD; Khatib, SA; Niu, M; Pruski, M; Rossi, EL; Yang, P | 1 |
| Alexandre, EC; André, DM; Anhê, GF; Antunes, E; Calixto, MC; Naime, ACA; Sollon, C; Tavares, EBG | 1 |
| Ho, CT; Lai, CS; Pan, MH; Wu, JC | 1 |
| Alexandre, EC; André, DM; Antunes, E; Calmasini, FB; de Oliveira, MG; Silva, FH; Tavares, EBG; Zapparoli, A | 1 |
| Cheng, J; Feng, Q; Zheng, J; Zheng, S | 1 |
| Ding, S; Dong, J; Kim, M; Qin, L; Su, Y; Sun, J; Zhang, C; Zhou, Y | 1 |
| Aligholi, H; Alipour, F; Djalali, M; Gorji, A; Koohdani, F; Mousavi, SMM; Noorbakhsh, F; Pishva, H; Safahani, M | 1 |
| Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Tsai, WL; Yu, HR | 1 |
| Feng, D; Feng, X; Feng, Z; Jia, Z; Li, H; Wang, H; Wang, L; Xu, D; Zhao, X | 1 |
| Aligholi, H; Alizadeh, L; Djalali, M; Gorji, A; Koohdani, F; Modarres Mousavi, SM; Noorbakhsh, F; Pishva, H; Safahani, M | 1 |
| Bendik, I; Blaak, EE; Boekschoten, MV; de Groot, P; Friedel, A; Goossens, GH; Jocken, JWE; Most, J; Warnke, I | 1 |
| Bairwa, SC; Dyck, JRB; Kim, TT; Levasseur, J; Madsen, K; Parajuli, N; Schertzer, JD; Soltys, CM; Sung, MM; Wishart, DS | 1 |
| Bibby, BM; Grønbaek, H; Nellemann, B; Nielsen, S; Pedersen, SB; Poulsen, MK; Stødkilde-Jørgensen, H | 1 |
| Bai, Y; Chen, C; Cui, J; Lin, C; Wu, L; Zhang, H | 1 |
| Bai, Y; Cui, J; Lin, C; Song, W; Su, M; Sun, M; Wu, L; Zhang, H | 1 |
| Bernardi, A; de Sá Coutinho, D; Frozza, RL; Pacheco, MT | 1 |
| Bai, YP; Cui, JQ; Lin, C; Song, WW; Su, M; Wu, L; Zhang, HY | 1 |
| Irwin-Houston, JM; Kornicka, K; Marycz, K; Weiss, C | 1 |
| Alexandre, EC; André, DM; Antunes, E; Calmasini, FB; de Oliveira, MG; Delbin, MA; Mónica, FZ; Silva, FH; Sponton, ACDS | 1 |
| Bellentani, S; Cicero, AFG; Colletti, A | 1 |
| Kulashekar, M; Peuler, JD; Stom, SM | 1 |
| Fernández-Quintela, A; Gómez-Zorita, S; González, M; Portillo, MP; Trepiana, J | 2 |
| Jin, X; Koniaris, LG; Zhang, Z; Zimmers, TA | 1 |
| Aguirre, L; Etxeberria, U; Martínez, JA; Milagro, FI; Milton-Laskibar, I; Portillo, MP | 1 |
| Lu, X; Lu, Y; Wang, L; Yang, W | 1 |
| Akbari, M; Asemi, Z; Dabbaghmanesh, MH; Dadgostar, E; Kolahdooz, F; Lankarani, KB; Momen-Heravi, M; Shamshirian, A; Tabrizi, R; Tamtaji, OR | 1 |
| Cheang, WS; Cheng, CK; Huang, Y; Lau, CW; Ma, RCW; Tian, XY; Wang, L; Wang, N; Wong, WT; Xu, A | 1 |
| Esmaillzadeh, A; Feinle-Bisset, C; Kord-Varkaneh, H; Larijani, B; Milajerdi, A; Mousavi, SM; Sheikhi, A | 1 |
| Bhatnagar, A; Pannu, N | 1 |
| Feng, X; Li, Q; Liao, W; Liu, Z; Yin, X; Zhang, H; Zheng, L; Zheng, X | 1 |
| Moco, S; Springer, M | 1 |
| Cheng, K; Li, S; Song, Z; Wang, C; Wang, T; Zhang, H; Zhang, L | 1 |
| Chen, F; Hu, X; Ke, W; Li, D; Liang, D; Wang, P | 1 |
| Gupta, SC; Kaschula, CH; Maiti, P; Rai, V; Singh, AP; Singh, R; Verma, SS | 1 |
| Andrade, JMO; Barcala-Jorge, AS; Batista-Jorge, GC; de Paula, AMB; Freitas, KM; Guimarães, ALS; Lelis, DF; Paraíso, AF; Santos, SHS | 1 |
| Blaak, EE; Boekschoten, M; Fazelzadeh, P; Hankemeier, T; Hoefsloot, HCJ; Kersten, S; Most, J; van Duynhoven, J | 1 |
| Breen, DM; Desai, T; Giacca, A; Ivovic, A; Koulajian, K; Luu, L; Tsiani, EL; Wheeler, MB | 1 |
| Chen, K; Hou, P; Huang, Y; Lang, H; Mi, M; Ran, L; Yi, L; Zhang, Q; Zhang, Y; Zheng, J; Zhou, M; Zhu, X | 1 |
| Bai, B; Chen, H; Liang, G; Liu, H; Shan, X; Sun, C; Wu, B; Zhang, W; Zhang, Y | 1 |
| Barzilai, N; Crandall, JP | 1 |
| Avila, PR; De Souza, CT; Engelmann, J; Lira, FS; Luciano, TF; Marques, SO; Pereira, SV; Pinho, RA; Souza, DR; Vitto, MF | 1 |
| Cabrera, RM; Ciolino, HP; Gulvady, AA; Jolly, CA | 1 |
| Blaak, EE; Holst, JJ; Knop, FK; Konings, E; Schrauwen, P; Timmers, S | 1 |
| Berry, NM; Bryan, J; Buckley, JD; Coates, AM; Howe, PR; Kunz, I; Wong, RH | 1 |
| Fujiwara, Y; Fukuhara, K; Hasebe, M; Ishii, A; Ito-Nagahata, T; Iwabuchi, M; Kurihara, C; Matsuoka, A; Sawada, R; Sonoda, M; Yamashita, K | 1 |
| Alberdi, G; Churruca, I; Macarulla, MT; Miranda, J; Portillo, MP; Rodríguez, VM | 2 |
| Arkell, AM; Beaudoin, MS; Holloway, GP; Simpson, JA; Snook, LA; Wright, DC | 1 |
| Jessen, N; Jørgensen, JO; Pedersen, SB; Poulsen, MM; Richelsen, B | 1 |
| Hesselink, MK; Schrauwen, P; Timmers, S | 1 |
| Barger, JL | 1 |
| Afman, LA; Blaak, EE; Boekschoten, MV; Goossens, GH; Jocken, JW; Konings, E; Mariman, EC; Müller, M; Schrauwen, P; Timmers, S | 1 |
| Dash, S; Lewis, GF; Morgantini, C; Szeto, L; Xiao, C | 1 |
| Allard, JS; Baur, JA; Belman, JP; Bernier, M; Bogan, JS; de Cabo, R; Egan, JM; Ferrucci, L; Herbert, RL; Jimenez-Gomez, Y; Lewis, K; Longo, DL; Malagon, MM; Martin-Montalvo, A; Mattison, JA; Moaddel, R; Morrell, CH; Navas, P; Palacios, HH; Pearson, KJ; Sanghvi, M; Sossong, AM; Tilmont, EM; Ward, TM; Younts, CM | 1 |
| Babu, JR; Broderick, TL; Geetha, T; Huggins, KW; Kumar, S; Mathews, ST; Rege, SD; Tamura, L; Wilson, DN | 1 |
| Bai, J; Le, G; Li, X; Shi, Y; Sun, J; Wang, B; Zhou, Q | 1 |
| Ho, CT; Lai, CS; Pan, MH; Tsai, ML | 1 |
| Bapat, P; Chen, L; Kwun, I; Mo, H; Moustaid-Moussa, N; Shastri, A; Shen, CL; Su, R; Wang, S | 1 |
| Choi, MS; Jeon, SM; Lee, SA | 1 |
| Li, CP; Lv, ZM; Rong, YL; Wang, CL; Wang, HJ; Wang, Q | 1 |
| Baek, SH; Chung, HJ; D'Souza, R; Hong, ST; Jeon, Y; Kim, HJ; Kweon, SJ; Lee, HK | 1 |
| Giri, PR; Majumdar, AS; Pai, SA | 1 |
| Bertrand, C; Cadoudal, T; Carpéné, C; Gomez, A; Gomez-Zorita, S; Grès, S; Gupta, R; Iffiu-Soltész, Z; Mercader, J; Rancoule, C | 1 |
| Koh, KK; Lim, S; Quon, MJ | 1 |
| Campagnole-Santos, MJ; de Paula, AM; dos Santos, RA; Ferreira, AV; Garcia, ZM; Guimarães, AL; Oliveira Andrade, JM; Paraíso, AF; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Le, G; Qiao, Y; Shi, Y; Sun, J; Tang, X; Xia, S | 1 |
| Mariman, EC; Noben, JP; Renes, J; Rosenow, A; Roumans, N | 1 |
| Le, G; Li, L; Shi, Y; Sun, J; Wang, B; Zheng, J | 1 |
| da Silva Lima, N; de Moura, EG; Franco, JG; Lisboa, PC; Maia, LA; Oliveira, E; Passos, MC; Peixoto-Silva, N | 1 |
| Chini, EN; Clasen, BF; Escande, C; Jessen, N; Jørgensen, JO; Møller, N; Pedersen, SB; Poulsen, MM | 1 |
| Carpene, C; Carpene, MA; Deleruyelle, S; Gomez-Zorita, S | 1 |
| Almendros, I; Carreras, A; Gozal, D; Peris, E; Qiao, Z; Wang, Y; Zhang, SX | 1 |
| Harsløf, T; Kjær, TN; Langdahl, BL; Ornstrup, MJ; Pedersen, SB | 1 |
| Brianti, MT; Gambero, A; Gotardo, EM; Piraee, M; Ribeiro, ML; Santos, JC | 1 |
| Alvarez, J; de la Fuente, S; Fonteriz, RI; Montero, M; Moreno, A | 1 |
| Aguirre, L; Arias, N; Fernández-Quintela, A; Portillo, MP | 1 |
| de Ligt, M; Schrauwen, P; Timmers, S | 1 |
| Bitterman, JL; Chung, JH | 1 |
| Fjeldborg, K; Kjær, TN; Nøhr, MK; Ornstrup, MJ; Pedersen, SB; Poulsen, MM | 1 |
| Koter-Michalak, M; Maćczak, A; Pytel, E; Sicińska, P | 1 |
| Arias, N; Boqué, N; Etxeberria, U; Macarulla, MT; Martínez, JA; Milagro, FI; Portillo, MP | 1 |
| Mensink, RP; Plat, J; van der Made, SM | 1 |
| Albuquerque Maia, L; Dias-Rocha, CP; Fernandes, TP; Franco, JG; Lisboa, PC; Moura, EG; Pazos-Moura, CC; Trevenzoli, IH | 1 |
| Aguirre, L; Arias, N; Macarulla, MT; Miranda, J; Portillo, MP | 1 |
| Baur, JA; Breen, DM; Côté, CD; Daljeet, M; Duca, FA; Filippi, BM; Lam, TK; Rasmussen, BA; Zadeh-Tahmasebi, M | 1 |
| Buechler, NL; McCall, CE; Vachharajani, VT; Wang, X; Yoza, BK | 1 |
| Hashimoto, K; Ikuta, T; Saito, S; Tani, H; Tatefuji, T | 1 |
| Lee, HJ; Lim, Y; Yang, SJ | 1 |
| Chang, CI; Han, CH; Hou, WC; Hsieh, YY; Huang, GC; Lin, SY; Lin, YS; Wen, CL | 1 |
| Kanauchi, O; Kitao, S; Kusano, K; Ohara, K; Takata, R; Yanai, T | 1 |
| Chang, CC; Day, YJ; Hung, LM; Lin, KY; Peng, KY | 1 |
| Christensen, LP; Dudele, A; Ebbesen, LH; Jessen, N; Lund, S; Nøhr, MK; Pedersen, SB; Poulsen, MM; Radko, Y; Richelsen, B | 1 |
| Kim, WK; Moseti, D; Regassa, A | 1 |
| Coleman, MA; Gavin, CF; Gilliam, D; Heyward, FD; Kaas, G; Lewis, J; Moulden, J; Sweatt, JD; Trieu, R; Wang, J | 1 |
| Aragonès, G; Ardid-Ruiz, A; Bladé, C; Ibars, M; Suárez, M | 1 |
| Noszál, B; Orgován, G | 1 |
| Fenning, AS; Irwin, JC; Phyu, HE; Vella, RK | 1 |
| Bendik, I; Blaak, EE; de Groot, P; Goossens, GH; Jocken, JW; Most, J; Schrauwen, P; Timmers, S; van Boekschoten, M; Warnke, I | 1 |
| Anwar, A; Fowler, M; Jenkins, G; Kandala, NB; Messenger, D; Qureshi, S; Rabbani, N; Shafie, A; Thornalley, PJ; Waldron, M; Weickert, MO; Xue, M | 1 |
| Arzola-Paniagua, MA; Calvo-Vargas, CG; García-Salgado López, ER; Guevara-Cruz, M | 1 |
| Cheserek, MJ; Karangwa, E; Le, G; Li, L; Shi, Y; Wu, G | 1 |
| Alexandre, EC; André, DM; Antunes, E; Calmasini, FB; da Silva, CPV; de Oliveira, MG; Delbin, MA; Leonardo, FC; Silva, FH | 1 |
| Chen, Y; Feng, F; Gan, L; Liu, G; Liu, Z; Sun, C; Wu, T | 1 |
| Alexandre, EC; André, DM; Anhê, GF; Antunes, E; Calixto, MC; Leiria, LO; Sollon, C; Tobar, N | 1 |
| Christenson, J; McKune, A; Mellor, D; Naumovski, N; Roach, PD; Thomas, J; Whitby, SJ | 1 |
| Al Sayah, L; Bachschmid, MM; Cohen, RA; Fry, JL; Seta, F; Van Roy, I; Weisbrod, RM; Weng, X | 1 |
| Enghild, JJ; Knudsen, AD; Kroager, TP; Nøhr, MK; Pedersen, SB; Richelsen, B; Sanggaard, KW; Stensballe, A; Ølholm, J | 1 |
| Chen, G; Huang, H; Liao, D; Pu, R; Xue, X; Zhu, Y | 1 |
| Bae, JW; Hyun, DW; Jung, MJ; Kim, MS; Kim, PS; Lee, J; Shin, NR; Whon, TW; Yun, JH | 1 |
| Ding, S; He, Q; Ji, L; Qi, Z; Xia, J; Xue, X | 1 |
| Chen, LL; Hu, X; Kong, W; Wang, SX; Wei, JG | 1 |
| Cui, X; Jing, X; Wu, X; Yan, M | 1 |
| Dodson, MV; Du, M; Fu, X; Jiang, Q; Liang, X; Rodgers, BD; Wang, S; Yang, Q; Zhu, M | 1 |
| Chen, D; Du, M; Nathanielsz, PW; Wang, B; Yang, Q; Zhu, MJ; Zou, T | 1 |
| Byrne, NJ; Denou, E; Dyck, JR; Hamza, SM; Kim, TT; Madsen, KL; Masson, G; Park, H; Schertzer, JD; Soltys, CM; Sung, MM; Wishart, DS | 1 |
| Aguirre, L; Carpéné, C; Contreras, J; Fernández, M; Fernández-Quintela, A; Milton-Laskibar, I; Portillo, MP | 1 |
| Aguirre, L; Contreras, J; Etxeberria, U; Macarulla, MT; Martínez, JA; Milagro, FI; Milton-Laskibar, I; Portillo, MP | 1 |
| Gu, H; He, J; Jiang, M; Li, X; Liu, L; Liu, X; Xu, X; Yu, X | 1 |
| Kjær, TN; Korsholm, AS; Ornstrup, MJ; Pedersen, SB | 1 |
| Bennetzen, MF; Paulsen, SK; Pedersen, SB; Richelsen, B; Ølholm, J | 1 |
| Ambati, S; Baile, CA; Della-Fera, MA; Hausman, DB; Park, HJ; Rayalam, S; Yang, JY | 1 |
| Iliff, BW; Mayers, JR; Swoap, SJ | 1 |
| Galisteo, M; Morón, R; Rivera, L; Zarzuelo, A | 1 |
| Alcaín, FJ; Villalba, JM | 1 |
| Pretorius, E; van der Spuy, WJ | 1 |
| Anton, SD; Bernabei, R; Carter, CS; Leeuwenburgh, C; Marzetti, E; Wohlgemuth, SE | 1 |
| Haigis, MC; Laurent, G; Lomb, DJ | 1 |
| Durand, C; Fröjdö, S; Pirola, L | 1 |
| Fullerton, MD; Steinberg, GR | 1 |
| Baur, JA | 2 |
| Campbell, RK; Gates, BJ; Levien, TL; Robinson, JD; Sonnett, TE | 1 |
| Szkudelska, K; Szkudelski, T | 1 |
| Cullberg, KB; Olholm, J; Paulsen, SK; Pedersen, SB; Richelsen, B | 1 |
| Berry, NM; Buckley, JD; Coates, AM; Howe, PR; Kunz, I; Wong, RH | 1 |
| Kelly, G | 1 |
| Kelly, GS | 1 |
| Andersen, C; Baile, CA; Della-Fera, MA; Hartzell, DL; Lai, CY; Rayalam, S; Yang, JY | 1 |
| Aguirre, L; Arias, N; Gómez-Zorita, S; Macarulla, MT; Martínez, JA; Martínez-Castaño, MG; Miranda, J; Portillo, MP | 1 |
| Baile, CA; Della-Fera, MA; Rayalam, S | 1 |
| Baur, JA; Hausenblas, HA; Smoliga, JM | 1 |
| Aguirre, L; Bujanda, L; Fernández-Quintela, A; Gómez-Zorita, S; Hijona, E; Macarulla, MT; Martínez, JA; Milagro, F; Portillo, MP | 1 |
| Guan, J; Han, CH; Hong, HJ; Kang, W; Kim, DG; Koh, G; Lee, DH; Lee, YJ; Park, D; Yang, EJ | 1 |
| Chen, S; Li, W; Li, Z; Shan, Z; Zhu, W | 1 |
| Auwerx, J; Bilet, L; Blaak, E; Goossens, GH; Hesselink, MKC; Hoeks, J; Houtkooper, RH; Kersten, S; Konings, E; Kunz, I; Moonen-Kornips, E; Ryu, D; Schrauwen, P; Schrauwen-Hinderling, VB; Timmers, S; van de Weijer, T; van der Krieken, S | 1 |
| Louis, XL; MohanKumar, SK; Netticadan, T; Taylor, CG; Thandapilly, SJ; Yu, L; Zahradka, P | 1 |
| Hasan, ST; Meydani, M | 1 |
| Ahmad, F; Baar, K; Beaven, MA; Brown, AL; Burgin, AB; Chung, JH; Ke, H; Kim, MK; Luo, H; Manganiello, V; Park, SJ; Philp, A; Rehmann, H; Taussig, R; Williams, T | 1 |
| Cho, GJ; Choi, WS; Jeon, BT; Jeong, EA; Kang, SS; Kim, HJ; Lee, DH; Lee, Y; Roh, GS; Shin, HJ | 1 |
| Cho, SJ; Choi, MS; Jung, UJ | 1 |
| Corkey, BE; Ferrante, T; Haller, JF; Krawczyk, SA; Zoeller, RA | 1 |
| Amininejad, L; De Groote, D; Devière, J; Mukaneza, A; Van Belleghem, K; Van Brussel, W | 1 |
| Accili, D; Farmer, SR; Gu, W; Kon, N; Lee, S; Qiang, L; Rosenbaum, M; Wang, L; Zhang, Y; Zhao, W; Zhao, Y | 1 |
| Amaral, TA; Franco, JG; Lima, NS; Lisboa, PC; Moura, EG; Oliveira, E; Passos, MC; Peixoto-Silva, N; Resende, AC | 1 |
| Christensen, LP; Clasen, BF; Jessen, N; Jørgensen, JO; Møller, N; Pedersen, SB; Poulsen, MM; Radko, Y; Stødkilde-Jørgensen, H; Vestergaard, PF | 1 |
| Blagosklonny, MV; Demidenko, ZN; Leontieva, OV; Paszkiewicz, G | 1 |
| Jinnouchi, T; Kai, S; Nagao, K; Yanagita, T | 1 |
| Check, E | 1 |
| Allard, JS; Baur, JA; Becker, KG; Boss, O; de Cabo, R; Fishbein, KW; Gwinn, D; Ingram, DK; Jamieson, HA; Kalra, A; Lakatta, EG; Le Couteur, D; Lerin, C; Lewis, K; Lopez-Lluch, G; Navas, P; Pearson, KJ; Pistell, PJ; Poosala, S; Prabhu, VV; Price, NL; Puigserver, P; Ramaswamy, S; Shaw, RJ; Sinclair, DA; Spencer, RG; Wang, M | 1 |
| Kaeberlein, M; Rabinovitch, PS | 1 |
| Argmann, C; Auwerx, J; Daussin, F; Elliott, P; Geny, B; Gerhart-Hines, Z; Laakso, M; Lagouge, M; Lambert, P; Lerin, C; Messadeq, N; Meziane, H; Milne, J; Puigserver, P | 1 |
| Koo, SH; Montminy, M | 1 |
| Aloe, L; Chaldakov, GN; Dimitrov, D; Fiore, M; Pancheva, R; Rancic, G; Tonchev, AB | 1 |
| Bak, I; Das, DK; Das, M; Das, S; Gesztelyi, R; Juhasz, B; Lekli, I; Szabo, G; Szendrei, L; Tosaki, A; Varadi, J; Varga, E | 1 |
| Aubin, MC; Calderone, A; Clément, R; Gosselin, H; Lajoie, C; Perrault, LP | 1 |
| Elliott, PJ; Jirousek, M | 1 |
| Doyle, PJ; Naderali, EK; Smith, SL; Williams, G | 1 |
65 review(s) available for resveratrol and Obesity
| Article | Year |
|---|---|
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol | 2022 |
Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature.
Topics: Dietary Supplements; Dysbiosis; Gastrointestinal Microbiome; Humans; Obesity; Resveratrol | 2022 |
Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Obesity; PPAR gamma; Resveratrol | 2022 |
Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations.
Topics: Animals; Diabetes Mellitus, Type 2; Female; Humans; Male; Mice; Obesity; Resveratrol; Stilbenes; Vitis | 2023 |
Effect of resveratrol on adipokines and myokines involved in fat browning: Perspectives in healthy weight against obesity.
Topics: Adipokines; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Humans; Obesity; Resveratrol | 2019 |
The effect of almond intake on anthropometric indices: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Anthropometry; Body Mass Index; Body Weight; Fats; Female; Humans; Male; Middle Aged; Obesity; Prunus dulcis; Randomized Controlled Trials as Topic; Resveratrol; Seeds; Waist Circumference; Young Adult | 2020 |
What is the effect of resveratrol on obesity? A systematic review and meta-analysis.
Topics: Body Mass Index; Body Weight; Humans; Obesity; Overweight; Resveratrol | 2021 |
The effect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: a systematic review of human intervention trials.
Topics: Adult; Aged; Antioxidants; Bias; Curcumin; Diabetes Mellitus, Type 2; Humans; Isothiocyanates; Middle Aged; NF-E2-Related Factor 2; Obesity; Oxidative Stress; Phytochemicals; Polyphenols; Resveratrol; Sulfoxides | 2021 |
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions.
Topics: Curcumin; Humans; Insulin Resistance; Liver; Liver Transplantation; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Plant Preparations; Resveratrol; Risk Factors | 2021 |
Antioxidant and Anti-Inflammatory Potential of Polyphenols Contained in Mediterranean Diet in Obesity: Molecular Mechanisms.
Topics: Anti-Inflammatory Agents; Antioxidants; Diet, Mediterranean; Dietary Fiber; Humans; NF-kappa B; Obesity; Polyphenols; Resveratrol | 2021 |
The role of resveratrol in diabetes and obesity associated with insulin resistance.
Topics: Animals; Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Resveratrol; Stilbenes | 2023 |
Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling.
Topics: Adipogenesis; Adipose Tissue; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Curcumin; Diet; Dietary Supplements; Endoplasmic Reticulum; Fatty Acids, Unsaturated; Humans; Inflammation; Insulin Resistance; Intestines; Lipids; Macrophages; Obesity; Polyphenols; Resveratrol; Signal Transduction; Thermogenesis | 2021 |
The Role of Resveratrol Administration in Human Obesity.
Topics: Anti-Obesity Agents; Antioxidants; Humans; Obesity; Resveratrol | 2021 |
Effects of Maternal Resveratrol Intake on the Metabolic Health of the Offspring.
Topics: Animals; Antioxidants; Female; Humans; Infant, Newborn; Lactation; Life Style; Male; Maternal Nutritional Physiological Phenomena; Obesity; Pregnancy; Resveratrol | 2021 |
Can resveratrol modulate sirtuins in obesity and related diseases? A systematic review of randomized controlled trials.
Topics: Diet; Humans; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Sirtuins | 2021 |
Antiobesity effects of resveratrol: which tissues are involved?
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Obesity Agents; Humans; Liver; Muscle, Skeletal; Obesity; Resveratrol; Stilbenes | 2017 |
Significance of Resveratrol in Clinical Management of Chronic Diseases.
Topics: Aging; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Neoplasms; Obesity; Polyphenols; Resveratrol; Stilbenes | 2017 |
Dietary (Poly)phenols, Brown Adipose Tissue Activation, and Energy Expenditure: A Narrative Review.
Topics: Adipose Tissue, Brown; Adrenergic Agonists; Animals; Anti-Obesity Agents; Body Weight; Diet; Disease Models, Animal; Energy Metabolism; Flavonoids; Humans; Obesity; Polyphenols; Resveratrol; Stilbenes; Tea; Thermogenesis; Uncoupling Protein 1 | 2017 |
The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity.
Topics: Animals; Antioxidants; Curcumin; Disease Models, Animal; Humans; Mice; Obesity; Quercetin; Rats; Resveratrol; Stilbenes | 2017 |
Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota.
Topics: Animals; Anti-Obesity Agents; Cardiovascular Diseases; Diet, High-Fat; Energy Metabolism; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Obesity; Resveratrol; Stilbenes | 2017 |
Resveratrol-Induced Effects on Body Fat Differ Depending on Feeding Conditions.
Topics: Adipose Tissue; Animals; Body Weight; Clinical Trials as Topic; Diet; Drug Evaluation, Preclinical; Energy Metabolism; Humans; Obesity; Resveratrol; Stilbenes | 2017 |
Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene.
Topics: Adipocytes; Adipokines; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Obesity Agents; Diet, High-Fat; Energy Metabolism; Gastrointestinal Microbiome; Gene Expression; Humans; Obesity; Resveratrol; Signal Transduction; Stilbenes; Thermogenesis | 2018 |
Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications.
Topics: Animals; Diabetes, Gestational; Female; Humans; Maternal Exposure; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Resveratrol | 2018 |
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Inflammation; Mice; Neoplasms; Obesity; Rats; Respiratory Tract Diseases; Resveratrol; Stilbenes | 2018 |
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Topics: Antioxidants; Berberine; Curcumin; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Observational Studies as Topic; Plant Extracts; Probiotics; Randomized Controlled Trials as Topic; Resveratrol; Salvia miltiorrhiza; Silymarin; Ubiquinone; Vitamin D; Vitamin E; Xanthophylls | 2018 |
Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer.
Topics: Alzheimer Disease; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Humans; Obesity; Resveratrol | 2018 |
The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adiponectin; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Leptin; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Weight Loss | 2020 |
Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials.
Topics: Adiposity; Antioxidants; Body Mass Index; Body Weight; Dietary Supplements; Humans; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Treatment Outcome; Waist Circumference | 2019 |
Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biological Availability; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Drug Delivery Systems; Humans; Neoplasms; Obesity; Protein Biosynthesis; Resveratrol | 2019 |
Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity.
Topics: Adiposity; Animals; Energy Metabolism; Gastrointestinal Microbiome; Humans; Insulin Resistance; Models, Animal; Obesity; Phytoalexins; Polyphenols; Resveratrol; Sesquiterpenes | 2019 |
Health benefits of resveratrol: Evidence from clinical studies.
Topics: Animals; Antioxidants; Diabetes Mellitus; Humans; Metabolic Syndrome; Neoplasms; Obesity; Resveratrol | 2019 |
Resveratrol in metabolic health: an overview of the current evidence and perspectives.
Topics: Animals; Caloric Restriction; Clinical Trials as Topic; Dietary Supplements; Energy Metabolism; Humans; Metabolic Diseases; Obesity; Resveratrol; Sirtuin 1; Stilbenes | 2013 |
Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Insurance Benefits; Obesity; Resveratrol; Stilbenes | 2013 |
An adipocentric perspective of resveratrol as a calorie restriction mimetic.
Topics: Adipose Tissue; Adiposity; Animals; Biomimetic Materials; Caloric Restriction; Humans; Obesity; Resveratrol; Stilbenes | 2013 |
Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Topics: Adipokines; Animals; Carotenoids; Curcumin; Fatty Acids, Omega-3; Fatty Liver; Flavonols; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Polyphenols; Resveratrol; Stilbenes | 2014 |
Novel insights of dietary polyphenols and obesity.
Topics: Adipocytes; Animals; Catechin; Cell Differentiation; Curcumin; Diet; Humans; Obesity; Plant Extracts; Polyphenols; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Tea | 2014 |
Modulation of adiponectin as a potential therapeutic strategy.
Topics: Adiponectin; Antihypertensive Agents; Atherosclerosis; Bariatric Surgery; Cardiovascular Diseases; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Metabolic Syndrome; Metabolism, Inborn Errors; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, Adiponectin; Resveratrol; Stilbenes | 2014 |
Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
Topics: Adipocytes; Animals; Diabetes Mellitus; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Polyphenols; Resveratrol; Stilbenes | 2015 |
Resveratrol: anti-obesity mechanisms of action.
Topics: Adipocytes; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; CCAAT-Enhancer-Binding Proteins; Down-Regulation; Fatty Acids; Humans; Lipogenesis; Liver; Muscle, Skeletal; Obesity; PPAR gamma; Resveratrol; Stilbenes | 2014 |
Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?
Topics: Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Humans; Mitochondria; Obesity; Resveratrol; Sirtuins; Stilbenes | 2015 |
Metabolic effects of resveratrol: addressing the controversies.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cyclic Nucleotide Phosphodiesterases, Type 4; Diabetes Mellitus, Type 2; Humans; Longevity; Neuroprotective Agents; Obesity; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Humans; Inflammation; Obesity; Resveratrol; Stilbenes; Translational Research, Biomedical | 2015 |
[The use of various diet supplements in metabolic syndrome].
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Calcium; Caloric Restriction; Diabetes Mellitus, Type 2; Dietary Supplements; Fatty Acids, Omega-3; Garlic; Humans; Magnesium; Metabolic Syndrome; Obesity; Panax; Photinia; Phytotherapy; Plant Preparations; Resveratrol; Risk Reduction Behavior; Selenium; Stilbenes; Tea; Zinc | 2015 |
Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules.
Topics: Adipocytes; Adipogenesis; Adiponectin; Adipose Tissue; Animals; CCAAT-Enhancer-Binding Protein-delta; CCAAT-Enhancer-Binding Proteins; Fatty Acid Synthase, Type I; Fatty Acid-Binding Proteins; Gene Expression Regulation; Genistein; Humans; Hydroxycholesterols; Mice; Obesity; PPAR gamma; Protein Isoforms; Resveratrol; Signal Transduction; Stilbenes | 2016 |
Modulation of leptin resistance by food compounds.
Topics: Agouti-Related Protein; Animals; Blood-Brain Barrier; Caffeine; Eating; Food; Hypothalamus; Leptin; Low Density Lipoprotein Receptor-Related Protein-2; Neurons; Neuropeptide Y; Obesity; Pentacyclic Triterpenes; Pro-Opiomelanocortin; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Receptors, Leptin; Resveratrol; Saponins; Stilbenes; Taurine; Triterpenes | 2016 |
[Resveratrol in Pharmaceutical Chemistry].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Blood Glucose; Cardiovascular System; Chemistry, Pharmaceutical; Dietary Supplements; Humans; Hungary; Obesity; Resveratrol; Solubility; Stilbenes | 2015 |
The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials.
Topics: Anti-Inflammatory Agents; Dietary Supplements; Humans; Obesity; Overweight; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Weight Loss | 2016 |
The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials.
Topics: Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Humans; Insulin Resistance; Meta-Analysis as Topic; Obesity; Overweight; Randomized Controlled Trials as Topic; Reproducibility of Results; Resveratrol; Risk Factors; Stilbenes | 2016 |
Anti-obesity effects of resveratrol: comparison between animal models and humans.
Topics: Animals; Anti-Obesity Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Obesity; Resveratrol; Stilbenes | 2016 |
Sirtuin activators.
Topics: Animals; Biological Availability; Drug Delivery Systems; Drug Design; Enzyme Activators; Flavonoids; Humans; Obesity; Phenols; Polyphenols; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2009 |
Is the use of resveratrol in the treatment and prevention of obesity premature?
Topics: Adult; Animals; Antioxidants; Child; Drug Administration Schedule; Humans; Inflammation; Intra-Abdominal Fat; Kidney; Obesity; Phenols; Plant Extracts; Resveratrol; Stilbenes | 2009 |
Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives.
Topics: Aged; Animals; Antioxidants; Apoptosis; Autophagy; Caloric Restriction; Cardiovascular Diseases; Disease Models, Animal; Forecasting; Heart Diseases; Homeostasis; Humans; Inflammation; Inflammation Mediators; Mitochondria, Heart; Mitochondrial Diseases; Obesity; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2009 |
Sirtuins regulate key aspects of lipid metabolism.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Caloric Restriction; Dietary Fats; Enzyme Activation; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Liver; Mice; Models, Biological; Muscle, Skeletal; Obesity; Resveratrol; Sirtuins; Stilbenes | 2010 |
Metabolic effects of resveratrol in mammals--a link between improved insulin action and aging.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Humans; Insulin; Insulin-Secreting Cells; Longevity; Mammals; Mice; Obesity; Resveratrol; Signal Transduction; Stilbenes | 2008 |
Resveratrol, sirtuins, and the promise of a DR mimetic.
Topics: ADP Ribose Transferases; Animals; Diet; Diet, Reducing; Energy Metabolism; Humans; Longevity; Obesity; Primates; Resveratrol; Saccharomyces cerevisiae; Sirtuins; Stilbenes | 2010 |
Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Antioxidants; Diabetes Mellitus; Ghrelin; Humans; Hypoglycemic Agents; Inflammation; Leptin; Obesity; Resveratrol; Stilbenes | 2010 |
Resveratrol, obesity and diabetes.
Topics: Animals; Diabetes Mellitus; Humans; Obesity; Resveratrol; Stilbenes | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Learning; Longevity; Memory; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Longevity; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
Effect of resveratrol on fat mobilization.
Topics: Adipogenesis; Adipose Tissue; Animals; Humans; Lipolysis; Obesity; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis.
Topics: Adipocytes; Animals; Caloric Restriction; Drug Synergism; Humans; Lipolysis; Obesity; Osteoblasts; Osteoporosis; Resveratrol; Stilbenes | 2011 |
Resveratrol and health--a comprehensive review of human clinical trials.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Dietary Supplements; Humans; Liver; Obesity; Oxidative Stress; Resveratrol; Stilbenes; Wine | 2011 |
Dietary polyphenols and obesity.
Topics: Adipogenesis; Animals; Anthocyanins; Catechin; Cells, Cultured; Curcumin; Diet; Energy Metabolism; Fruit; Humans; Obesity; Polyphenols; Resveratrol; Stilbenes; Tea | 2010 |
Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight.
Topics: Brain-Derived Neurotrophic Factor; Caloric Restriction; Energy Metabolism; Glucose; Humans; Lipid Metabolism; Nerve Growth Factor; Nutritional Physiological Phenomena; Obesity; Resveratrol; Stilbenes | 2007 |
Sirtuins: novel targets for metabolic disease.
Topics: Base Sequence; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Enzyme Inhibitors; Humans; Metabolic Diseases; Molecular Sequence Data; Molecular Structure; Obesity; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2008 |
21 trial(s) available for resveratrol and Obesity
| Article | Year |
|---|---|
Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial.
Topics: Adiponectin; Adult; Female; Follicle Stimulating Hormone; Humans; Inositol; Insulin; Luteinizing Hormone; Metformin; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Resveratrol; Stress, Psychological; Testosterone; Young Adult | 2023 |
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program.
Topics: Administration, Oral; Adult; Dietary Supplements; Energy Metabolism; Female; Humans; Life Style; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Placebos; Resveratrol | 2020 |
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
Resveratrol supplementation reduces ACE2 expression in human adipose tissue.
Topics: Adipose Tissue; Angiotensin-Converting Enzyme 2; COVID-19; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Down-Regulation; Humans; Leptin; Male; Middle Aged; Obesity; Placebo Effect; Receptor, Angiotensin, Type 1; Resveratrol; SARS-CoV-2 | 2021 |
The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans.
Topics: Adipose Tissue; Adult; Catechin; Dietary Supplements; Double-Blind Method; Female; Gene Expression; Humans; Male; Obesity; Overweight; Polyphenols; Resveratrol | 2018 |
No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
Topics: Adult; Body Composition; Glucose Clamp Technique; Humans; Insulin Resistance; Kinetics; Lipoproteins, VLDL; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Resveratrol; Triglycerides | 2018 |
Global testing of shifts in metabolic phenotype.
Topics: Catechin; Dietary Supplements; Double-Blind Method; Humans; Metabolomics; Obesity; Phenotype; Resveratrol; Weight Loss | 2018 |
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Topics: Antioxidants; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Postprandial Period; Resveratrol; Stilbenes; Time Factors; Treatment Outcome | 2013 |
Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Brachial Artery; Carotid Arteries; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Obesity; Overweight; Postmenopause; Resveratrol; Stilbenes; Stroop Test; Surveys and Questionnaires; Vasodilation | 2013 |
The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adult; Aged; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Gene Expression Profiling; Humans; Male; Middle Aged; Obesity; Receptors, Notch; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome; Wnt Signaling Pathway | 2014 |
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
Topics: Adult; Analysis of Variance; Apolipoprotein B-100; Apolipoprotein B-48; Biomarkers; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Intestinal Mucosa; Intestines; Lipoproteins; Liver; Male; Middle Aged; Obesity; Ontario; Overweight; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Triglycerides | 2013 |
Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Antioxidants; Bone and Bones; Bone Density; Double-Blind Method; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Patient Compliance; Resveratrol; Stilbenes | 2014 |
Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
Topics: Aged; Apolipoprotein A-I; Biomarkers; Cardiovascular Diseases; Cross-Over Studies; Female; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Resveratrol; Stilbenes | 2015 |
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Topics: Adult; Blood Glucose; Catechin; Dietary Supplements; Double-Blind Method; Energy Metabolism; Fasting; Female; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Male; Mitochondria; Muscles; Obesity; Plant Extracts; Postprandial Period; Resveratrol; Stilbenes | 2016 |
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Cell Line; Cross-Over Studies; Female; Glutathione; Glutathione Disulfide; Hep G2 Cells; Hesperidin; Humans; Lactoylglutathione Lyase; Male; Middle Aged; Models, Biological; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Stilbenes; Young Adult | 2016 |
Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: A randomized controlled trial.
Topics: Adult; Aged; Anthropometry; Anti-Obesity Agents; Body Mass Index; Caloric Restriction; Diet; Double-Blind Method; Drug Therapy, Combination; Energy Intake; Female; Humans; Lactones; Leptin; Male; Mexico; Middle Aged; Obesity; Orlistat; Placebos; Resveratrol; Stilbenes; Treatment Outcome; Triglycerides; Weight Loss | 2016 |
Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Overweight; Placebos; Resveratrol; Risk Factors; Stilbenes; Vasodilation | 2011 |
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
Topics: Adipose Tissue; Alanine Transaminase; AMP-Activated Protein Kinase Kinases; Blood Glucose; Blood Pressure; Caloric Restriction; Citrate (si)-Synthase; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Fatty Acids; Glycerol; Heat-Shock Proteins; Humans; Liver; Male; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Netherlands; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Kinases; Resveratrol; Sirtuin 1; Stilbenes; Switzerland; Transcription Factors; Triglycerides | 2011 |
Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects.
Topics: Adult; Antioxidants; Biomarkers; Catechin; Dietary Supplements; Female; Gene Expression; Grape Seed Extract; Humans; Male; Microarray Analysis; Middle Aged; Obesity; Organophosphates; Oxidative Stress; Resveratrol; Stilbenes | 2012 |
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
Topics: Adolescent; Adult; Aged; Antioxidants; Body Composition; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Energy Metabolism; Gene Expression Regulation; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Resveratrol; Stilbenes; Young Adult | 2013 |
144 other study(ies) available for resveratrol and Obesity
| Article | Year |
|---|---|
Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Disease Models, Animal; Fasting; Glucose Tolerance Test; Hyperglycemia; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Salicylates; Stilbenes; Structure-Activity Relationship; Styrenes; Weight Gain | 2008 |
Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Anti-Obesity Agents; Antioxidants; Drug Evaluation, Preclinical; Lipid Metabolism; Mice; Obesity; Polyphenols; Zebrafish | 2018 |
Comprehensive assessment of the effectiveness of l-carnitine and transresveratrol in rats with diet-induced obesity.
Topics: Animals; Carnitine; Diet, High-Fat; Male; Obesity; Rats; Rats, Wistar; Resveratrol | 2022 |
Resveratrol for Weight Loss in Obesity: An Assessment of Randomized Control Trial Designs in ClinicalTrials.gov.
Topics: Humans; Infant, Newborn; Obesity; Resveratrol; Weight Loss | 2022 |
Protective Effects of Dietary Resveratrol against Chronic Low-Grade Inflammation Mediated through the Gut Microbiota in High-Fat Diet Mice.
Topics: Animals; Diet, High-Fat; Gastrointestinal Microbiome; Inflammation; Mice; Mice, Inbred C57BL; Obesity; Resveratrol | 2022 |
Protective effects of apple polyphenols on bone loss in mice with high fat diet-induced obesity.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Diet, High-Fat; Inflammation; Male; Mice; Mice, Inbred C57BL; Obesity; Polyphenols; Resveratrol; X-Ray Microtomography | 2022 |
Synergistic Beneficial Effects of Resveratrol and Diet on High-Fat Diet-Induced Obesity.
Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Diet, High-Fat; Fatty Acids; Glucose; Insulin; Lipids; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sirtuin 1; Sirtuin 3 | 2022 |
Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management.
Topics: Adipocytes; Adipogenesis; Animals; Berberine; beta Catenin; Cholesterol; Curcumin; Cytokines; Fatty Acids; Glucose; Hesperidin; Humans; Lipoproteins, LDL; Luteolin; Mice; Obesity; Phytochemicals; PPAR gamma; Quercetin; Resveratrol; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2022 |
In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Capsaicin; Genome-Wide Association Study; Humans; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Polymorphism, Single Nucleotide; Resveratrol | 2023 |
Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1.
Topics: Adipokines; Adiposity; Animals; Diet; Diet, High-Fat; Insulin; Insulin-Like Growth Factor I; Lipids; Liver; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Rats; Resveratrol; Tumor Necrosis Factor-alpha | 2023 |
Resveratrol inhibits the formation and accumulation of lipid droplets through AdipoQ signal pathway and lipid metabolism lncRNAs.
Topics: Animals; Lipid Droplets; Lipid Metabolism; Male; Obesity; Phosphatidylinositol 3-Kinases; Resveratrol; RNA, Long Noncoding; Signal Transduction; Swine | 2023 |
Germinated Rice Seeds Improved Resveratrol Production to Suppress Adipogenic and Inflammatory Molecules in 3T3-L1 Adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Cell Differentiation; Mice; Obesity; Oryza; PPAR gamma; Resveratrol; Seeds; Transcription Factors | 2023 |
Resveratrol and Metformin Recover Prefrontal Cortex AMPK Activation in Diet-Induced Obese Mice but Reduce BDNF and Synaptophysin Protein Content.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Autophagy; Blood Glucose; Brain-Derived Neurotrophic Factor; Diet, High-Fat; Enzyme Activation; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Mice; Mice, Inbred C57BL; Obesity; Prefrontal Cortex; Resveratrol; Synaptophysin; TOR Serine-Threonine Kinases | 2019 |
Resveratrol and Oxyresveratrol Activate Thermogenesis via Different Transcriptional Coactivators in High-Fat Diet-Induced Obese Mice.
Topics: Animals; Diet, High-Fat; DNA-Binding Proteins; Energy Metabolism; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sirtuin 1; Thermogenesis; Transcription Factors; Uncoupling Protein 1 | 2019 |
Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.
Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Disease Models, Animal; Disease Progression; Humans; Janus Kinase 2; Leptin; Male; Mice; Mice, Inbred C57BL; Obesity; Osteoarthritis; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein | 2020 |
Adrenomedullin has a role in angiogenic effects of resveratrol in adipose tissues of obese female rats.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adrenomedullin; Animals; Antioxidants; Diet, High-Fat; Energy Metabolism; Female; Gene Expression; Injections, Intraperitoneal; Obesity; Rats, Sprague-Dawley; Resveratrol; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2020 |
Comparative proteomics reveals protective effect of resveratrol on a high-fat diet-induced damage to mice testis.
Topics: Animals; Diet, High-Fat; Drug Evaluation, Preclinical; Male; Mice; Mice, Inbred C57BL; Obesity; Protein Interaction Mapping; Proteomics; Random Allocation; Resveratrol; Spermatogenesis; Spermatozoa; Testis | 2020 |
Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1 macrophage polarization and increasing the regulatory T cell population.
Topics: Animals; Cell Polarity; Humans; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Macrophages; Male; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; p38 Mitogen-Activated Protein Kinases; Resveratrol; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 2020 |
Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota.
Topics: Animals; Diet, High-Fat; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Obesity; Phylogeny; Resveratrol; RNA, Ribosomal, 16S | 2020 |
Maternal Resveratrol Treatment Re-Programs and Maternal High-Fat Diet-Induced Retroperitoneal Adiposity in Male Offspring.
Topics: Adiposity; Animals; Diet, High-Fat; Female; Male; Maternal Nutritional Physiological Phenomena; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Topics: Animals; Antioxidants; Bacteroides; Body Weight; Clostridiales; Diet, High-Fat; Fatty Liver; Firmicutes; Gastrointestinal Microbiome; Inflammation; Insulin Resistance; Intestinal Mucosa; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Resveratrol | 2020 |
Effects of Maternal Resveratrol on Maternal High-Fat Diet/Obesity with or without Postnatal High-Fat Diet.
Topics: Adiponectin; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diet, High-Fat; Female; Humans; Insulin Resistance; Male; Maternal Nutritional Physiological Phenomena; Maze Learning; Obesity; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Resveratrol; Weaning | 2020 |
Resveratrol intake during pregnancy and lactation re-programs adiposity and ameliorates leptin resistance in male progeny induced by maternal high-fat/high sucrose plus postnatal high-fat/high sucrose diets via fat metabolism regulation.
Topics: Adiposity; Analysis of Variance; Animals; Blotting, Western; Body Weight; Diet, High-Fat; Eating; Female; Lactation; Lipid Metabolism; Lipogenesis; Lipolysis; Male; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1 | 2020 |
Effect of resveratrol on behavioral, biochemical, and immunological parameters of DBA/2J and tetrahybrid DBCB mice receiving diet with excess fat and fructose.
Topics: Animals; Antioxidants; Behavior, Animal; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Elevated Plus Maze Test; Fructose; Ghrelin; Inflammation; Insulin Resistance; Interleukin-10; Interleukin-3; Leptin; Male; Mice; Mice, Inbred DBA; Obesity; Resveratrol; Triglycerides | 2021 |
Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Cognitive Dysfunction; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Humans; Male; Memory Disorders; Mice; Mice, Transgenic; Neuroprotection; Neuroprotective Agents; Obesity; Proteasome Endopeptidase Complex; Proteolysis; Resveratrol; Ubiquitin | 2021 |
Resveratrol Supplementation Attenuates Cognitive and Molecular Alterations under Maternal High-Fat Diet Intake: Epigenetic Inheritance over Generations.
Topics: Adenosine; Animals; Body Weight; Brain; Cognition; Diet, High-Fat; Dietary Supplements; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Inflammation; Leptin; Male; Maternal Exposure; Maze Learning; Methylation; Mice; Neurodegenerative Diseases; Neuronal Plasticity; Obesity; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Resveratrol; Triglycerides | 2021 |
Effect of Resveratrol, L-Carnitine, and Aromatic Amino Acid Supplements on the Trace Element Content in the Organs of Mice with Dietary-Induced Obesity.
Topics: Amino Acids, Aromatic; Animals; Carnitine; Diet, High-Fat; Dietary Supplements; Mice; Mice, Inbred DBA; Obesity; Resveratrol; Trace Elements | 2022 |
Browning white adipose tissue using adipose stromal cell-targeted resveratrol-loaded nanoparticles for combating obesity.
Topics: Adipose Tissue, White; Animals; Mice; Mice, Inbred C57BL; Nanoparticles; Obesity; Resveratrol; Stromal Cells; Thermogenesis | 2021 |
Resveratrol improves muscle regeneration in obese mice through enhancing mitochondrial biogenesis.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cell Differentiation; Diet, High-Fat; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mitochondria, Muscle; Muscle Development; Muscle, Skeletal; Obesity; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Regeneration; Resveratrol | 2021 |
Resveratrol Butyrate Esters Inhibit Obesity Caused by Perinatal Exposure to Bisphenol A in Female Offspring Rats.
Topics: Animals; Benzhydryl Compounds; Butyric Acid; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Obesity; Phenols; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Resveratrol | 2021 |
Resveratrol derivative BTM-0512 mitigates obesity by promoting beige remodeling of subcutaneous preadipocytes.
Topics: Adipocytes; Adipose Tissue, Beige; Adipose Tissue, Brown; Animals; Blotting, Western; Body Weight; Cells, Cultured; Diet, High-Fat; DNA-Binding Proteins; Gene Expression; Humans; Male; Mice, Inbred C57BL; Molecular Structure; Obesity; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Stilbenes; Subcutaneous Fat; Transcription Factors; Uncoupling Protein 1 | 2017 |
Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes.
Topics: 3T3 Cells; Adipocytes; Adult; Animals; Biological Transport; Caffeine; Cell Differentiation; Female; Glucose; Glycerol; Humans; Insulin; Lipogenesis; Lipolysis; Mice; Middle Aged; Obesity; Resveratrol; Stilbenes | 2017 |
The effect of obesity and repeated exposure on pharmacokinetic response to grape polyphenols in humans.
Topics: Aged; Anti-Obesity Agents; Area Under Curve; Body Mass Index; Dietary Supplements; Female; Fruit; Fruit and Vegetable Juices; Humans; Kinetics; Male; Middle Aged; Obesity; Overweight; Pilot Projects; Plant Extracts; Polyphenols; Resveratrol; Seeds; Stilbenes; Vitis | 2017 |
Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
Topics: Adipocytes; Adipokines; Adipose Tissue; Animals; Body Weight; Breast Neoplasms; Cell Cycle; Cell Proliferation; Coculture Techniques; Culture Media, Conditioned; Endocrine System; Female; Humans; Male; MCF-7 Cells; Obesity; Rats; Rats, Zucker; Resveratrol; Stilbenes; Time Factors | 2017 |
Rosiglitazone is superior to resveratrol in inducing the expression of glyceroneogenic genes in adipose tissue from obese participants.
Topics: Adipose Tissue; Adult; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Obesity; Pregnancy; Resveratrol; Rosiglitazone; Stilbenes; Thiazolidinediones; Tissue Culture Techniques | 2018 |
A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota.
Topics: Animals; Bacteria; Diet, High-Fat; Dysbiosis; Gastrointestinal Microbiome; Humans; Male; Obesity; Quercetin; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2017 |
Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Models, Animal; Female; Mice, Inbred C57BL; Obesity; Postmenopause; Resveratrol | 2018 |
High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol.
Topics: Allergens; Animals; Asthma; Diet, High-Fat; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phosphorylation; Pneumonia; Receptor, Insulin; Resveratrol; Signal Transduction | 2017 |
Obesity-induced mouse benign prostatic hyperplasia (BPH) is improved by treatment with resveratrol: implication of oxidative stress, insulin sensitivity and neuronal growth factor.
Topics: Animals; Body Weight; Insulin Resistance; Male; Mice, Inbred C57BL; NADPH Oxidase 2; Nerve Growth Factor; Obesity; Oxidative Stress; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol | 2018 |
Early potential effects of resveratrol supplementation on skeletal muscle adaptation involved in exercise-induced weight loss in obese mice.
Topics: Animals; Diet, High-Fat; Glucose; Homeostasis; Lipids; Male; Mice; Mice, Inbred ICR; Mice, Obese; Muscle, Skeletal; Obesity; Physical Conditioning, Animal; Resveratrol; Stilbenes; Transcription Factors; Weight Loss | 2018 |
Resveratrol promotes the arcuate nucleus architecture remodeling to produce more anorexigenic neurons in high-fat-diet-fed mice.
Topics: Animals; Appetite Depressants; Arcuate Nucleus of Hypothalamus; Diet, High-Fat; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Neurons; Obesity; Resveratrol | 2018 |
Combined maternal and postnatal high-fat diet leads to metabolic syndrome and is effectively reversed by resveratrol: a multiple-organ study.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Female; Glucose Tolerance Test; Male; Maternal Nutritional Physiological Phenomena; Metabolic Syndrome; Obesity; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resveratrol; Sirtuin 1; Triglycerides | 2018 |
Resveratrol reverses the adverse effects of a diet-induced obese murine model on oocyte quality and zona pellucida softening.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Female; Humans; Meiosis; Mice; Mice, Inbred C57BL; Obesity; Oocytes; Oxidative Stress; Resveratrol; Stilbenes; Zona Pellucida | 2018 |
Switching from high-fat diet to foods containing resveratrol as a calorie restriction mimetic changes the architecture of arcuate nucleus to produce more newborn anorexigenic neurons.
Topics: Animals; Antioxidants; Arcuate Nucleus of Hypothalamus; Caloric Restriction; Diet, High-Fat; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Obesity; Resveratrol | 2019 |
Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice.
Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Colon; Cytokines; Diet, High-Fat; Dietary Sucrose; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Hyperglycemia; Hypertension; Inflammation; Magnetic Resonance Spectroscopy; Metabolic Syndrome; Mice; Obesity; Resveratrol | 2018 |
[Effects of exercise and resveratrol on visceral fat resistin expression and plasma resistin concentration in elderly obese rats].
Topics: Adipose Tissue; Aging; Animals; Blood Glucose; Insulin; Insulin Resistance; Intra-Abdominal Fat; Obesity; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Resistin; Resveratrol | 2016 |
[Effects of exercise and resveratrol on retinol binding protein 4, blood glucose and insulin sensitivity in aged obese rats].
Topics: Adipose Tissue; Aged; Animals; Blood Glucose; Exercise; Humans; Insulin; Insulin Resistance; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Retinol-Binding Proteins, Plasma | 2017 |
[Effects of different intensities exercise combined with resveratrol on RBP4 in aged obese rats].
Topics: Aging; Animals; Insulin Resistance; Male; Obesity; Physical Conditioning, Animal; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Retinol-Binding Proteins, Plasma; Stilbenes | 2017 |
Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.
Topics: Adipose Tissue; Animals; Autophagy; Azacitidine; Cell Differentiation; Cellular Senescence; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Drug Combinations; Female; Gene Expression Regulation; Horse Diseases; Horses; Insulin Resistance; Male; Mesenchymal Stem Cells; Metabolic Syndrome; Mitochondrial Dynamics; Obesity; Osteoblasts; Osteogenesis; Osteopontin; Oxidative Stress; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Signal Transduction; Ubiquitin-Protein Ligases | 2018 |
Influence of the periprostatic adipose tissue in obesity-associated mouse urethral dysfunction and oxidative stress: Effect of resveratrol treatment.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle Relaxation; NADPH Oxidase 2; Nitric Oxide; Obesity; Oxidative Stress; Prostate; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Superoxide Dismutase-1; Tumor Necrosis Factor-alpha; Urethra | 2018 |
Resveratrol and Pterostilbene, Two Analogue Phenolic Compounds, Affect Aquaglyceroporin Expression in a Different Manner in Adipose Tissue.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Aquaglyceroporins; Diet, High-Fat; Gene Expression Regulation; Male; Obesity; Rats, Wistar; Resveratrol; Stilbenes; Triglycerides | 2018 |
Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.
Topics: A549 Cells; Animals; Cell Proliferation; Diet, High-Fat; Disease Models, Animal; ErbB Receptors; Hepatectomy; Humans; Liver; Liver Regeneration; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Phosphorylation; Proto-Oncogene Proteins c-akt; Recovery of Function; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Up-Regulation | 2019 |
Do the Effects of Resveratrol on Thermogenic and Oxidative Capacities in IBAT and Skeletal Muscle Depend on Feeding Conditions?
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Caloric Restriction; Diet, High-Fat; Energy Intake; Energy Metabolism; Fatty Acids; Feeding Behavior; Glucose; Lipid Metabolism; Male; Mitochondria; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Plant Extracts; Polyphenols; PPAR alpha; Rats, Wistar; Resveratrol; Sirtuin 1; Thermogenesis | 2018 |
Resveratrol attenuates high fat diet-induced mouse cardiomyopathy through upregulation of estrogen related receptor-α.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cardiotonic Agents; Diet, High-Fat; ERRalpha Estrogen-Related Receptor; Male; Mice, Inbred C57BL; Myocardium; Obesity; Receptors, Estrogen; Resveratrol; Up-Regulation | 2019 |
Resveratrol ameliorates endothelial dysfunction in diabetic and obese mice through sirtuin 1 and peroxisome proliferator-activated receptor δ.
Topics: Animals; Diabetes Mellitus, Experimental; Endothelial Cells; Endothelium, Vascular; Humans; Male; Mice, Inbred C57BL; Mice, Transgenic; Obesity; PPAR delta; Resveratrol; Sirtuin 1 | 2019 |
Resveratrol-Induced White Adipose Tissue Browning in Obese Mice by Remodeling Fecal Microbiota.
Topics: Adipose Tissue, White; Animals; Diet, High-Fat; Feces; Gastrointestinal Microbiome; Male; Mice; Microbiota; Obesity; Random Allocation; Resveratrol; Sirtuin 1 | 2018 |
The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Topics: Animals; Diet, High-Fat; Fatty Liver; Gene Expression; Inflammation; Insulin; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Resveratrol; Transcription, Genetic | 2019 |
Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice.
Topics: Animals; Diet, High-Fat; Gastrointestinal Microbiome; Intestinal Mucosa; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Resveratrol | 2020 |
Effect of resveratrol on expression of genes involved thermogenesis in mice and humans.
Topics: Adipocytes; Adipose Tissue; Adult; Animals; Diet, High-Fat; Female; Fibronectins; Healthy Volunteers; Humans; Male; Mice; Middle Aged; Obesity; Primary Cell Culture; Resveratrol; Sirtuin 1; Thermogenesis | 2019 |
Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivo.
Topics: Animals; Female; Insulin-Secreting Cells; Male; Mice; Mice, Transgenic; Obesity; Oleic Acid; Rats; Rats, Wistar; Resveratrol; Sirtuin 1 | 2019 |
Effects of resveratrol and its analogue pterostilbene, on NOV/CCN3 adipokine in adipose tissue from rats fed a high-fat high-sucrose diet.
Topics: Adipose Tissue; Adiposity; Animals; Diet, Carbohydrate Loading; Diet, High-Fat; Immediate-Early Proteins; Male; Obesity; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sucrose | 2019 |
Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway.
Topics: Adenylate Kinase; Aging; AMP-Activated Protein Kinase Kinases; Animals; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Diet, High-Fat; Male; Mitochondria; Muscle Fibers, Skeletal; Muscular Atrophy; Obesity; Oxidative Stress; Palmitic Acid; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Resveratrol; Sarcopenia; Signal Transduction | 2019 |
A novel resveratrol analog PA19 attenuates obesity‑induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Diet, High-Fat; Fibrosis; Heart; Heart Injuries; Inflammation; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Obesity; Resveratrol | 2019 |
Exploring the promise of resveratrol: where do we go from here?
Topics: Antioxidants; Body Composition; Humans; Insulin Resistance; Male; Obesity; Resveratrol; Stilbenes | 2013 |
Resveratrol and fish oil reduce catecholamine-induced mortality in obese rats: role of oxidative stress in the myocardium and aorta.
Topics: Animals; Antioxidants; Aorta; Catecholamines; Dietary Fats; Dietary Supplements; Fish Oils; Isoproterenol; Male; Microfilament Proteins; Myocardium; NF-E2-Related Factor 2; Obesity; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2013 |
Resveratrol inhibits the deleterious effects of diet-induced obesity on thymic function.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Carnitine O-Palmitoyltransferase; Diet, High-Fat; Dose-Response Relationship, Drug; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Resveratrol; Stilbenes; T-Lymphocytes; Thymus Gland | 2013 |
Stilbene analogs of resveratrol improve insulin resistance through activation of AMPK.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Humans; Insulin; Insulin Resistance; Mice; Obesity; Resveratrol; Stilbenes | 2013 |
Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats.
Topics: Adipose Tissue, Brown; Animals; Electron Transport Complex IV; Gene Expression Regulation; Humans; Male; Muscle, Skeletal; Obesity; PPAR alpha; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Thermogenesis | 2013 |
Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Diabetes Mellitus; Dietary Supplements; Male; Obesity; Rats; Rats, Zucker; Resveratrol; Stilbenes; Treatment Outcome | 2013 |
Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.
Topics: Adipocytes; Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbohydrates; Cell Line; Diet, High-Fat; Inflammation; Insulin; Macaca mulatta; Male; Mice; NF-kappa B; Obesity; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Transcriptome; Viscera | 2013 |
Resveratrol protects the brain of obese mice from oxidative damage.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Brain; Hydrogen Peroxide; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Obese; Neuroprotective Agents; Obesity; Oxidative Stress; Resveratrol; Stilbenes; Thinness | 2013 |
Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cytokines; Diet, High-Fat; Dietary Fats; Dietary Supplements; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Phytotherapy; Plant Extracts; Receptors, Aryl Hydrocarbon; Resveratrol; Spleen; Stilbenes; T-Lymphocytes, Regulatory | 2013 |
Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.
Topics: Animals; Anti-Obesity Agents; Anticholesteremic Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Humans; Lovastatin; Male; Mice; Mice, Knockout; Obesity; Protective Agents; Resveratrol; Stilbenes | 2014 |
Resveratrol appears to protect against oxidative stress and steroidogenesis collapse in mice fed high-calorie and high-cholesterol diet.
Topics: Animals; Antioxidants; Cholesterol; Diet; Energy Intake; Glutathione Peroxidase; Leydig Cells; Male; Mice; Obesity; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase; Phosphoproteins; Resveratrol; RNA, Messenger; Stilbenes; Superoxide Dismutase; Testis; Testosterone | 2015 |
Treatment of obesity with the resveratrol-enriched rice DJ-526.
Topics: Abdominal Fat; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Chromatography, High Pressure Liquid; Female; Lipids; Mice; Mice, Inbred C57BL; Obesity; Oryza; Plants, Genetically Modified; Resveratrol; Stilbenes | 2014 |
Resveratrol- and melatonin-abated ovariectomy and fructose diet-induced obesity and metabolic alterations in female rats.
Topics: Administration, Oral; Animals; Antioxidants; Diabetes Mellitus; Diet; Disease Models, Animal; Female; Fructose; Melatonin; Obesity; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2014 |
Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice.
Topics: Adipocytes; Adipogenesis; Animals; Blood Glucose; Body Composition; Diet, High-Fat; Dose-Response Relationship, Drug; Drinking Water; Glucose Tolerance Test; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Obesity; Phenelzine; Resveratrol; Stilbenes; Weight Gain | 2014 |
Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
Topics: Administration, Oral; Angiotensin I; Animals; Antimetabolites; Cells, Cultured; Diet, High-Fat; Drug Evaluation, Preclinical; Gene Expression; Glucose Intolerance; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Male; Mice; Obesity; Peptide Fragments; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Resistin; Resveratrol; Sirtuins; Stilbenes | 2014 |
Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity.
Topics: Acetyl-CoA Carboxylase; Adipose Tissue; Angiopoietin-Like Protein 4; Angiopoietins; Animals; Bifidobacterium; Blood Glucose; Body Weight; Diet, High-Fat; Enterococcus faecalis; fas Receptor; Gastrointestinal Tract; Lactobacillus; Lipids; Lipogenesis; Liver; Male; Mice; Microbiota; Obesity; PPAR gamma; Resveratrol; Signal Transduction; Stearoyl-CoA Desaturase; Stilbenes | 2014 |
Calorie restriction-induced changes in the secretome of human adipocytes, comparison with resveratrol-induced secretome effects.
Topics: Adipocytes; Adipokines; Adipose Tissue, White; Antioxidants; Arrhythmias, Cardiac; Caloric Restriction; Cells, Cultured; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation; Genetic Diseases, X-Linked; Gigantism; Glucose; Heart Defects, Congenital; Humans; Insulin Resistance; Intellectual Disability; Molecular Sequence Annotation; Obesity; Proteome; Proteomics; Resveratrol; Sirtuin 1; Stilbenes; Tandem Mass Spectrometry | 2014 |
Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Body Weight; Diet, High-Fat; Fasting; Female; Inflammation; Insulin; Leptin; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Obesity; Oxidative Stress; Phosphatidylinositol 3-Kinases; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; T-Lymphocyte Subsets | 2014 |
Resveratrol prevents hyperleptinemia and central leptin resistance in adult rats programmed by early weaning.
Topics: Animals; Female; Humans; Insulin; Janus Kinase 2; Lactation; Leptin; Male; Obesity; Rats; Rats, Wistar; Resveratrol; Stilbenes; Weaning | 2014 |
Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Antioxidants; Body Composition; Double-Blind Method; Human Growth Hormone; Mice; Muscles; Obesity; Resveratrol; Signal Transduction; Sirtuin 1; STAT5 Transcription Factor; Stilbenes | 2014 |
Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea.
Topics: Animals; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Eating; Inflammation; Insulin Resistance; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Obesity; Resveratrol; Sleep Apnea Syndromes; Stilbenes; Tumor Necrosis Factor-alpha; Weight Gain | 2015 |
Effects of yerba maté, a plant extract formulation ("YGD") and resveratrol in 3T3-L1 adipogenesis.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Antioxidants; Biomarkers, Tumor; Blotting, Western; Cell Differentiation; Cell Proliferation; Drug Combinations; Gene Expression Profiling; Gene Expression Regulation; Ilex paraguariensis; Mice; Obesity; Oligonucleotide Array Sequence Analysis; Plant Extracts; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes | 2014 |
Effects of long-term feeding of the polyphenols resveratrol and kaempferol in obese mice.
Topics: Alanine Transaminase; Animals; Blood Glucose; Body Weight; Cholesterol; Gene Expression Regulation; Insulin; Kaempferols; Liver; Male; Mice, Inbred C57BL; Obesity; Resveratrol; Rotarod Performance Test; Stilbenes; Survival Rate; Triglycerides | 2014 |
Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats.
Topics: Animals; Bacillus; Bacteroidetes; Diet, High-Fat; Dietary Supplements; DNA, Bacterial; Fatty Acids, Volatile; Feces; Firmicutes; Gas Chromatography-Mass Spectrometry; Gastrointestinal Microbiome; Gastrointestinal Tract; Insulin Resistance; Obesity; Quercetin; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sucrose; Weight Gain | 2015 |
Resveratrol treatment rescues hyperleptinemia and improves hypothalamic leptin signaling programmed by maternal high-fat diet in rats.
Topics: Adipose Tissue; Animals; Body Composition; Diet, High-Fat; Female; Hyperphagia; Hypothalamus; Janus Kinase 2; Leptin; Male; Maternal Nutritional Physiological Phenomena; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Suppressor of Cytokine Signaling 3 Protein; Weight Gain | 2016 |
Liver delipidating effect of a combination of resveratrol and quercetin in rats fed an obesogenic diet.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Diet, High-Fat; Drug Evaluation, Preclinical; Energy Intake; Gene Expression; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Quercetin; Rats, Wistar; Resveratrol; Stilbenes | 2015 |
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Nerve Net; Neurons; Niacinamide; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin | 2015 |
Resveratrol attenuates microvascular inflammation in sepsis via SIRT-1-Induced modulation of adhesion molecules in ob/ob mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cecum; Cell Adhesion Molecules; Female; Inflammation; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Platelet Adhesiveness; Resveratrol; Sepsis; Sirtuin 1; Stilbenes | 2015 |
Resveratrol derivative-rich melinjo (Gnetum gnemon L.) seed extract improves obesity and survival of C57BL/6 mice fed a high-fat diet.
Topics: Animals; Diet, High-Fat; Gnetum; Insulin; Male; Mice; Mice, Inbred C57BL; Motor Activity; Obesity; Plant Extracts; Resveratrol; Seeds; Stilbenes; Survival Analysis | 2015 |
Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitro.
Topics: Adipocytes; Adiponectin; alpha-2-HS-Glycoprotein; Animals; Body Weight; Coculture Techniques; Diet, High-Fat; Hepatocytes; Lipids; Liver; Male; Mice, Inbred C57BL; Obesity; Resveratrol; Stilbenes | 2015 |
Vitis thunbergii var. taiwaniana Extracts and Purified Compounds Ameliorate Obesity in High-Fat Diet-Induced Obese Mice.
Topics: Animals; Cholesterol; Diet, High-Fat; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phytotherapy; Plant Extracts; Plant Leaves; Plant Stems; Resveratrol; Stilbenes; Taiwan; Triglycerides; Vitis | 2015 |
ε-Viniferin, a resveratrol dimer, prevents diet-induced obesity in mice.
Topics: 3T3 Cells; Adipogenesis; Animals; Anti-Obesity Agents; Benzofurans; Diet, High-Fat; Dimerization; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Obesity; Resveratrol; Stilbenes; Treatment Outcome | 2015 |
Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Anti-Obesity Agents; Cell Death; Cell Differentiation; Diet, High-Fat; Dose-Response Relationship, Drug; Lipolysis; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Resveratrol; Stilbenes | 2016 |
LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.
Topics: Adipose Tissue; Animals; Antioxidants; Blood Glucose; Body Weight; Epididymis; Gene Expression Profiling; Glucose; Glucose Tolerance Test; Homeostasis; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Leukocytes; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Osmosis; Resveratrol; Stilbenes | 2016 |
Obesity Weighs down Memory through a Mechanism Involving the Neuroepigenetic Dysregulation of Sirt1.
Topics: Animals; Antioxidants; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; DNA Methylation; Excitatory Postsynaptic Potentials; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Insulin; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Obesity; Prosencephalon; Recognition, Psychology; Resveratrol; Sirtuin 1; Spatial Memory; Stilbenes; Time Factors | 2016 |
Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats.
Topics: Analgesics; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hyperalgesia; Male; Muscle Contraction; Nervous System; Obesity; Plant Extracts; Polyphenols; Random Allocation; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Cardioprotective effects of lipoic acid, quercetin and resveratrol on oxidative stress related to thyroid hormone alterations in long-term obesity.
Topics: Animals; Anti-Obesity Agents; Antihypertensive Agents; Antioxidants; Biomarkers; Cardiotonic Agents; Cardiovascular Diseases; Diet, High-Fat; Female; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypothyroidism; Mice, Inbred C57BL; Obesity; Oxidative Stress; Quercetin; Random Allocation; Resveratrol; Stilbenes; Thioctic Acid; Thyroid Hormones; Weight Gain | 2016 |
Chronic treatment with resveratrol improves overactive bladder in obese mice via antioxidant activity.
Topics: Administration, Oral; Animals; Anti-Obesity Agents; Antioxidants; Body Weight; Diet, High-Fat; Gene Expression Regulation, Enzymologic; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Muscle, Smooth; NADPH Oxidase 2; NADPH Oxidases; Obesity; Oxidative Stress; Resveratrol; RNA, Messenger; Stilbenes; Superoxide Dismutase-1; Time Factors; Urinary Bladder; Urinary Bladder, Overactive | 2016 |
Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Obesity Agents; Cells, Cultured; Diet, High-Fat; Enzyme Activation; Inflammation; Insulin; Male; Mice; Niacinamide; Obesity; Proto-Oncogene Proteins c-akt; Regulatory-Associated Protein of mTOR; Resveratrol; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sirtuin 1; Stilbenes; Subcutaneous Fat; TOR Serine-Threonine Kinases | 2016 |
Therapy with resveratrol attenuates obesity-associated allergic airway inflammation in mice.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Asthma; Cell Movement; Cells, Cultured; Disease Progression; Eosinophils; Lung; Mice; Mice, Inbred Strains; Obesity; Pneumonia; Resveratrol; Stilbenes | 2016 |
Vascular Smooth Muscle Sirtuin-1 Protects Against Diet-Induced Aortic Stiffness.
Topics: Animals; Blotting, Western; Cardiovascular Diseases; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; Obesity; Pulse Wave Analysis; Random Allocation; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Stilbenes; Vascular Cell Adhesion Molecule-1; Vascular Stiffness | 2016 |
SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics - Resveratrol as Ameliorating Factor on LPS Induced Changes.
Topics: Adipocytes; Adipose Tissue; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Gastrointestinal Microbiome; Gene Expression Regulation; Glycosylation; Humans; Inflammation; Insulin; Insulin Resistance; Lipid Metabolism; Lipogenesis; Lipopolysaccharides; N-Acetylgalactosaminyltransferases; Obesity; Polypeptide N-acetylgalactosaminyltransferase; Proteome; Proteomics; Resveratrol; Stilbenes | 2016 |
Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice.
Topics: Animals; Bacteria; Blood Glucose; Clostridium; Diet, High-Fat; Gastrointestinal Microbiome; Glucose Intolerance; Glucose Tolerance Test; Insulin; Intestines; Lactococcus; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Inbred C57BL; Obesity; Resveratrol; Signal Transduction; Sirolimus; Stilbenes | 2016 |
Long-term treatment with nicotinamide induces glucose intolerance and skeletal muscle lipotoxicity in normal chow-fed mice: compared to diet-induced obesity.
Topics: Animals; Antioxidants; Autophagy; Diet, High-Fat; Dietary Supplements; Gene Expression Regulation; Glucose Intolerance; Histone Deacetylase Inhibitors; Insulin Resistance; Lipid Metabolism; Male; Mice, Inbred C57BL; Mitophagy; Muscle Proteins; Muscle, Skeletal; Niacinamide; Obesity; Resveratrol; Sirtuin 1; Stilbenes; Time Factors | 2016 |
The role of expression imbalance between adipose synthesis and storage mediated by PPAR-γ/FSP27 in the formation of insulin resistance in catch up growth.
Topics: Adipocytes; Adipose Tissue; Animals; Apoptosis Regulatory Proteins; Caloric Restriction; Energy Intake; Epididymis; Epididymitis; Gene Expression Regulation; Humans; Insulin Resistance; Intra-Abdominal Fat; Male; Obesity; PPAR gamma; Proteins; Rats; Resveratrol; Stilbenes; Subcutaneous Fat | 2016 |
Protective effect of resveratrol on spermatozoa function in male infertility induced by excess weight and obesity.
Topics: Acrosin; Adult; Cell Survival; Cytoplasm; Gonadal Steroid Hormones; Humans; Infertility, Male; Male; Obesity; Overweight; Protective Agents; Resveratrol; Semen Analysis; Spermatozoa; Stilbenes; Zinc | 2016 |
Resveratrol enhances brown adipocyte formation and function by activating AMP-activated protein kinase (AMPK) α1 in mice fed high-fat diet.
Topics: Adipocytes, Brown; Adipogenesis; Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Ion Channels; Mice; Mitochondrial Proteins; Obesity; Resveratrol; Stilbenes; Thermogenesis; Transcription Factors | 2017 |
Resveratrol supplementation of high-fat diet-fed pregnant mice promotes brown and beige adipocyte development and prevents obesity in male offspring.
Topics: Adipocytes, Beige; Adipocytes, Brown; Animals; Diet, High-Fat; Energy Metabolism; Female; Male; Mice; Obesity; Pregnancy; Resveratrol; Stilbenes; Thermogenesis | 2017 |
Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome.
Topics: Animals; Bacteroides; Blood Glucose; Chromatography, Liquid; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Glucose; Glucose Tolerance Test; Homeostasis; Male; Mice; Mice, Obese; Obesity; Resveratrol; Stilbenes; Tandem Mass Spectrometry | 2017 |
Comparative effects of energy restriction and resveratrol intake on glycemic control improvement.
Topics: Adiponectin; Animals; Antioxidants; Blood Glucose; Caloric Restriction; Diet, High-Fat; Fructosamine; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Leptin; Male; Muscle, Skeletal; Obesity; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, Insulin; Resveratrol; Stilbenes; Sucrose; Triglycerides | 2017 |
Oral Administration of Resveratrol Alleviates Osteoarthritis Pathology in C57BL/6J Mice Model Induced by a High-Fat Diet.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Blotting, Western; Diet, High-Fat; Enzyme-Linked Immunosorbent Assay; Inflammation; Male; Mice; Mice, Inbred C57BL; Obesity; Osteoarthritis; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes | 2017 |
Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months' Treatment.
Topics: Adipose Tissue; Biomarkers; Blood Pressure; Gastrointestinal Microbiome; Humans; Insulin Resistance; Male; Metabolic Syndrome; Metabolomics; Middle Aged; Muscles; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2017 |
Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women.
Topics: Adipocytes; Adult; Cell Differentiation; Cells, Cultured; Enzyme Activation; Fasting; Female; Humans; Lipolysis; Middle Aged; Obesity; Resveratrol; RNA, Messenger; Sirtuin 1; Sirtuins; Stilbenes; Subcutaneous Fat; Thinness; Up-Regulation | 2008 |
Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Anti-Obesity Agents; Antioxidants; Apoptosis; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Female; Genistein; Glycerolphosphate Dehydrogenase; Humans; Lipids; Mice; Obesity; Phytoestrogens; Quercetin; Resveratrol; Stilbenes | 2008 |
Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction.
Topics: Animals; Anti-Obesity Agents; Bradycardia; Caloric Restriction; Exercise Test; Hypothermia; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Physical Endurance; Random Allocation; Resveratrol; Stilbenes; Time Factors | 2009 |
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
Topics: Adipose Tissue; Animals; Blood Pressure; Disease Models, Animal; Drug Administration Schedule; Humans; Hypertension; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Zucker; Resveratrol; Stilbenes | 2009 |
SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Insulin Resistance; Obesity; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants.
Topics: Adipocytes; Adipose Tissue; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Gene Expression; Humans; Inflammation; Male; Obesity; Resveratrol; RNA, Messenger; Stilbenes | 2010 |
The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity.
Topics: Adipose Tissue, White; Animals; Area Under Curve; Blood Glucose; Body Weight; Drug Evaluation, Preclinical; Drug Therapy, Combination; Energy Intake; Glucose Tolerance Test; Linoleic Acids, Conjugated; Lipids; Male; Obesity; Organ Size; Rats; Rats, Wistar; Resveratrol; Stilbenes; Treatment Failure | 2011 |
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
Topics: Acyl-CoA Oxidase; Animals; Antioxidants; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Fatty Acids; Fatty Liver; Isoenzymes; Lipid Metabolism; Lipids; Liver; Male; Obesity; Organ Size; Oxidative Stress; Random Allocation; Rats; Rats, Zucker; Resveratrol; Stilbenes; Up-Regulation | 2012 |
Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Dietary Fats; Inflammation; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phosphorylation; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Lipogenesis; Mice; Obesity; Phosphorylation; PPAR gamma; Resveratrol; Sterol Regulatory Element Binding Protein 1; Stilbenes | 2011 |
Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Blood Glucose; Diet, High-Fat; Disease Resistance; Disease Susceptibility; Echocardiography; Heart; Heart Diseases; Hyperglycemia; Hyperinsulinism; Male; Obesity; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue, White; Aging; AMP-Activated Protein Kinase Kinases; Animals; Caloric Restriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Diet; Glucose Intolerance; Guanine Nucleotide Exchange Factors; Mice; Models, Molecular; Muscle, Skeletal; NAD; Obesity; Protein Kinases; Resveratrol; Rolipram; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |
Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diet, High-Fat; Fatty Liver; Glucose Tolerance Test; Inflammation; Insulin Resistance; Male; Maze Learning; Memory Disorders; Mice; Obesity; Resveratrol; Stilbenes | 2012 |
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.
Topics: Adiposity; Animals; Cholesterol; Diet; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acid Synthases; Fatty Liver; Glucosephosphate Dehydrogenase; Hyperlipidemias; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphatidate Phosphatase; Resveratrol; Stilbenes; Triglycerides; Weight Gain | 2012 |
Reactive oxygen species facilitate translocation of hormone sensitive lipase to the lipid droplet during lipolysis in human differentiated adipocytes.
Topics: Acetylcysteine; Adipocytes; Adipose Tissue; Adult; Antioxidants; Biphenyl Compounds; Colforsin; Female; Humans; Lipids; Lipolysis; Middle Aged; Obesity; Onium Compounds; Phosphorylation; Primary Cell Culture; Protein Transport; Reactive Oxygen Species; Resveratrol; Serine; Signal Transduction; Sterol Esterase; Stilbenes | 2012 |
Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.
Topics: 3T3 Cells; Acetylation; Adipose Tissue, Brown; Adipose Tissue, White; Adult; Amino Acid Sequence; Animals; Cells, Cultured; Energy Metabolism; Female; Humans; Insulin Resistance; Ligands; Lysine; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Obesity; PPAR gamma; Resveratrol; Sequence Alignment; Sirtuin 1; Stilbenes; Thermogenesis; Thiazolidinediones | 2012 |
Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning.
Topics: Animals; Antioxidants; Blood Glucose; Dyslipidemias; Fatty Liver; Female; Glutathione Peroxidase; Hyperphagia; Hypertension; Insulin Resistance; Liver; Obesity; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weaning | 2013 |
Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
Topics: Acetylation; Acyl-CoA Oxidase; Adenylate Kinase; Adipose Tissue; Animals; Carnitine O-Palmitoyltransferase; Diet, High-Fat; Dietary Sucrose; Enzyme Activation; Fatty Acids; Lipid Metabolism; Liver; Male; Obesity; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Resveratrol; RNA-Binding Proteins; Sirtuin 1; Stilbenes; Transcription Factors; Triglycerides | 2013 |
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.
Topics: Animals; Cell Line, Tumor; Cellular Senescence; Diet, High-Fat; Humans; Hyperinsulinism; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Insulin Resistance; Male; Mice; Obesity; Resveratrol; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Transcription, Genetic; Weight Gain | 2013 |
Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats.
Topics: Adipose Tissue, White; Animals; Body Weight; Carnitine O-Palmitoyltransferase; Cholesterol; Food, Formulated; Gene Expression; Glycogen; Lipid Metabolism; Liver; Male; Metabolome; Obesity; Rats; Rats, Inbred OLETF; Resveratrol; RNA, Messenger; Stilbenes; Triglycerides; Up-Regulation | 2013 |
A votre santé: now in pill form?
Topics: Animals; Clinical Trials as Topic; Health; Humans; Mice; Obesity; Reproducibility of Results; Resveratrol; Sirtuins; Stilbenes | 2006 |
Resveratrol improves health and survival of mice on a high-calorie diet.
Topics: Acetylation; Adenylate Kinase; Animals; Energy Intake; Health; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Obesity; Oligonucleotide Array Sequence Analysis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Stilbenes; Survival Rate; Trans-Activators; Transcription Factors | 2006 |
Medicine: grapes versus gluttony.
Topics: Animals; Caloric Restriction; Energy Intake; Health; Humans; Insulin Resistance; Longevity; Mice; Obesity; Resveratrol; Stilbenes | 2006 |
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
Topics: Acetylation; Adult; Animals; Dietary Fats; Energy Metabolism; Gene Expression Regulation; Humans; Insulin Resistance; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mitochondria, Muscle; Motor Activity; Muscle Fibers, Skeletal; Obesity; Oxidative Phosphorylation; Oxygen Consumption; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Polymorphism, Single Nucleotide; Resveratrol; Sirtuin 1; Sirtuins; Specific Pathogen-Free Organisms; Stilbenes; Trans-Activators; Transcription Factors | 2006 |
In vino veritas: a tale of two sirt1s?
Topics: Acetylation; Administration, Oral; Aging; Animals; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose; Homeostasis; Humans; Insulin; Longevity; Male; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Trans-Activators; Transcription Factors | 2006 |
Obesity: do grapes hold the answer?
Topics: Animals; Diet; Enzyme Activation; Flavonoids; Humans; Mice; Obesity; Phenols; Polyphenols; Resveratrol; Sirtuins; Stilbenes; Vitis | 2007 |
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Blood Pressure; Electrocardiography; Endothelin-1; Glucose Transporter Type 4; Heart Rate; In Situ Nick-End Labeling; In Vitro Techniques; Insulin; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Obesity; Rats; Rats, Zucker; Resveratrol; Signal Transduction; Stilbenes | 2008 |
Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Blood Pressure; Dietary Fats; Female; Fibrosis; Hyperlipidemias; Myocardium; Nitroprusside; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left | 2008 |
The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats.
Topics: Acetylcholine; Animals; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Indomethacin; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Norepinephrine; Obesity; Rats; Rats, Wistar; Resveratrol; Stilbenes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |